Client News
Newron TRS study 6 months’ results: Evenamide substantially improves patients to an extent that they no longer meet protocol entry criteria
9th October 2023
Rentschler Biopharma and Friedrich-Adler-Realschule Laupheim sign cooperation agreement to enhance school education with additional practical experience
5th October 2023
Mainz Biomed Announces Live Launch of ColoAlert® with Bioclinica in Romania
4th October 2023
Newron to present three posters on its clinical program evaluating evenamide in the treatment of schizophrenia at the 36th European College of Neuropsychopharmacology Congress
4th October 2023
Carbios unveils major innovation in polyester recycling with new textile preparation line, in the presence of Roland Lescure, French Minister of Industry
2nd October 2023
Abivax highlights obefazimod ulcerative colitis program with new data to be presented at the UEG Week 2023
2nd October 2023
Abivax files registration statement for proposed initial public offering in the United States
29th September 2023
Abivax announces the release of its 2023 half-year financial report
29th September 2023
There is no more content to load